Innate immune cell populations function as initiators and effectors in Th2 cytokine responses

Trends in Immunology

Volumn 31, Issue 11, 2010, Pages 407-413

  Saenz, Steven A ^a   Noti, Mario ^a   Artis, David ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 25; INTERLEUKIN 33;

ALLERGY; CELL FUNCTION; CELL POPULATION; CYTOKINE RESPONSE; HELMINTHIASIS; HELPER CELL; HUMAN; INNATE IMMUNITY; NONHUMAN; REVIEW; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; CYTOKINES; HUMANS; IMMUNITY, INNATE; TH2 CELLS;

EID: 78049277883     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2010.09.001     Document Type: Review

References (53)

1. Abbas A.K., et al. Functional diversity of helper T lymphocytes. Nature 1996, 383(6603):787-793.
2. Finkelman F.D., et al. Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol. Rev. 2004, 201:139-155.
3. Anthony R.M., et al. Protective immune mechanisms in helminth infection. Nat. Rev. Immunol. 2007, 7:975-987.
4. Umetsu D.T., et al. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 2002, 3:715-720.
5. Holgate S.T., Polosa R. Treatment strategies for allergy and asthma. Nat. Rev. Immunol. 2008, 8:218-230.
6. Maizels R.M. Infections and allergy - helminths, hygiene and host immune regulation. Curr. Opin. Immunol. 2005, 17:656-661.
7. Paul W.E., Zhu J. How are T(H)2-type immune responses initiated and amplified?. Nat. Rev. Immunol. 2010, 10:225-235.
8. Buggiani G., et al. Atopic dermatitis. Dermatol. Ther. 2008, 21:96-100.
9. Eder W., et al. The asthma epidemic. N. Engl. J. Med. 2006, 355:2226-2235.
10. Kim H.Y., et al. The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat. Immunol. 2010, 11:577-584.
11. Carvalho E.M., et al. Worms and allergy. Parasite Immunol. 2006, 28:525-534.
12. Hotez P.J., et al. Control of neglected tropical diseases. N. Engl. J. Med. 2007, 357:1018-1027.
13. Alexopoulou L., et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
14. Pichlmair A., Reis e Sousa C. Innate recognition of viruses. Immunity 2007, 27:370-383.
15. Diebold S. Innate recognition of viruses. Immunol. Lett. 2010, 128:17-20.
16. Pamer E.G. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 2004, 4:812-823.
17. Miller C.M., et al. The immunobiology of the innate response to Toxoplasma gondii. Int. J. Parasitol. 2009, 39:23-39.
18. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
19. Mowen K.A., Glimcher L.H. Signaling pathways in Th2 development. Immunol. Rev. 2004, 202:203-222.
20. Reiner S.L. Development in motion: helper T cells at work. Cell 2007, 129:33-36.
21. Sokol C.L., et al. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol. 2008, 9:310-318.
22. Perrigoue J.G., et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat. Immunol. 2009, 10:697-705.
23. Niu N., et al. Cutting edge: limiting MHC class II expression to dendritic cells alters the ability to develop Th2- dependent allergic airway inflammation. J. Immunol. 2009, 183:1523-1527.
24. Tang H., et al. The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat. Immunol. 2010, 11:608-617.
25. Moro, K. et al. (2009) Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature (advance online publication).
26. Saenz S.A., et al. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010, 464:1362-1366.
27. Neill D.R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
28. Price A.E., et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:11489-11494.
29. Hurst S.D., et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 2002, 169:443-453.
30. Owyang A.M., et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J. Exp. Med. 2006, 203:843-849.
31. Rickel E.A., et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J. Immunol. 2008, 181:4299-4310.
32. Humphreys N.E., et al. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol. 2008, 180:2443-2449.
33. Oshikawa K., et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am. J. Respir. Crit. Care Med. 2001, 164:277-281.
34. Oshikawa K., et al. Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin. Exp. Allergy 2002, 32:1520-1526.
35. Kondo Y., et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int. Immunol. 2008, 20:791-800.
36. Saenz S.A., et al. Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol. Rev. 2008, 226:172-190.
37. Ziegler S.F., Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat. Immunol. 2010, 11:289-293.
38. Bulek K., et al. Epithelium: the interplay between innate and Th2 immunity. Immunol. Cell Biol. 2010, 88:257-268.
39. Fort M.M., et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 2001, 15:985-995.
40. Fallon P.G., et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 2006, 203:1105-1116.
41. Reya T., et al. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
42. Wilson A., et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008, 135:1118-1129.
43. Ganley-Leal L.M., et al. Higher percentages of circulating mast cell precursors correlate with susceptibility to reinfection with Schistosoma mansoni. Am. J. Trop. Med. Hyg. 2006, 75:1053-1057.
44. Allakhverdi Z., et al. CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J. Allergy Clin. Immunol. 2009, 123:472-478.
45. Hibino T., et al. The immune gene repertoire encoded in the purple sea urchin genome. Dev. Biol. 2006, 300:349-365.
46. Schmitz J., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
47. Yanagisawa K., et al. The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226 cells. J. Biochem. 1997, 121:95-103.
48. Dunne A., O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 2003, 2003:re3.
49. Schwarzenberger P., et al. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J. Immunol. 2000, 164:4783-4789.
50. Cella M., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457:722-725.
51. Satoh-Takayama N., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
52. Takatori H., et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2009, 206:35-41.
53. Buonocore S., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464:1371-1375.